These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1346837)

  • 21. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
    Herrstedt J; Ersbøll J; Dombernowsky P
    Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555
    [No Abstract]   [Full Text] [Related]  

  • 22. Ondansetron in radiation therapy of brain tumor in children.
    Lippens RJ; Broeders GC
    Pediatr Hematol Oncol; 1996; 13(3):247-52. PubMed ID: 8735340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of carboplatin induced emesis by ondansetron.
    Harvey VJ; Evans BD; Mitchell PL; Mak D; Neave LM; Langley GB; Dickson DS
    Br J Cancer; 1991 Jun; 63(6):942-4. PubMed ID: 1829954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced emesis: effects of ondansetron.
    Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens.
    Cubeddu LX; Hoffman IS; Fuenmayor NT; Finn AL
    J Clin Oncol; 1990 Oct; 8(10):1721-7. PubMed ID: 2145400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
    Horiot JC
    Acta Oncol; 2004 Sep; 43 Suppl 15():23-4. PubMed ID: 15370627
    [No Abstract]   [Full Text] [Related]  

  • 27. Blueprint for the control of radiation-induced nausea and vomiting. Introduction.
    Horiot JC
    Acta Oncol; 2004 Sep; 43 Suppl 15():3-4. PubMed ID: 15370622
    [No Abstract]   [Full Text] [Related]  

  • 28. Understanding anti-emetics.
    Pervan V
    Nurs Times; 1993 Mar 10-16; 89(10):36-8. PubMed ID: 8474887
    [No Abstract]   [Full Text] [Related]  

  • 29. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.
    Krobbuaban B; Pitakpol S; Diregpoke S
    J Med Assoc Thai; 2008 May; 91(5):669-74. PubMed ID: 18672630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of ondansetron in the prevention of nausea and vomiting after laparoscopic cholecystectomy].
    Cabrera JC; Matute E; Escolano F; Castillo J; Santiveri X; Castaño J
    Rev Esp Anestesiol Reanim; 1997 Jan; 44(1):36-8. PubMed ID: 9148349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
    Smith DB; Newlands ES; Spruyt OW; Begent RH; Rustin GJ; Mellor B; Bagshawe KD
    Br J Cancer; 1990 Feb; 61(2):323-4. PubMed ID: 2138031
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic intravenous ondansetron in patients undergoing cataract extraction under general anesthesia.
    Ascaso FJ; Ayala I; Carbonell P; Castro FJ; Palomar A
    Ophthalmologica; 1997; 211(5):292-5. PubMed ID: 9286804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of ondansetron in paediatric patients: a review of three studies.
    Stevens RF
    Eur J Cancer; 1991; 27 Suppl 1():S20-2. PubMed ID: 1831631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group.
    Seynaeve C; Schuller J; Buser K; Porteder H; Van Belle S; Sevelda P; Christmann D; Schmidt M; Kitchener H; Paes D
    Br J Cancer; 1992 Jul; 66(1):192-7. PubMed ID: 1386245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral treatment with ondansetron in an outpatient setting.
    Dicato MA
    Eur J Cancer; 1991; 27 Suppl 1():S18-9; discussion S22. PubMed ID: 1831630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy-induced nausea and vomiting.
    Dennis K; Maranzano E; De Angelis C; Holden L; Wong S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):685-92. PubMed ID: 22098284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study.
    Leksowski K; Peryga P; Szyca R
    Surg Endosc; 2006 Jun; 20(6):878-82. PubMed ID: 16738974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 40. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
    Smyth JF; Coleman RE; Nicolson M; Gallmeier WM; Leonard RC; Cornbleet MA; Allan SG; Upadhyaya BK; Bruntsch U
    BMJ; 1991 Dec; 303(6815):1423-6. PubMed ID: 1837743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.